Skip to main content
. Author manuscript; available in PMC: 2013 Mar 25.
Published in final edited form as: Curr Opin Cardiol. 2011 May;26(3):216–222. doi: 10.1097/HCO.0b013e328345980a

Table 1.

Autophagy in human cardiovascular disease

Cardiovascular disease Sample source No. of
patients
Methods to detect autophagy Autophagic
activity
Reference
Heart failure (DCM) Ventriculectomy 27 EM Increased [10]
Heart failure
 (unclassified cardiomyopathy)
Endomyocardial biopsy 1 EM Increased [1]
Heart failure (idiopathic DCM) Explanted hearts 19 EM, ubiquitinated proteins Increased [12]
Heart failure (idiopathic DCM, LVAD) Explanted hearts 9 Beclin 1, ATG5, LC3II mRNA
 and protein level
Decreased
 after LVAD
[13••]
Glycogen storage disease Animal model of human
 disease
N/A EM Decreased [14•]
Ischemic heart disease
 (ischemia–reperfusion)
Animal model of human
 disease
N/A EM, Beclin 1, LC3, cathepsin D Increased [15]
Anticancer drug-induced
 cardiomyopathy (doxorubicin)
Animal model of human
 disease
N/A EM, Beclin 1 Increased [16•]
Anticancer drug-induced
 cardiomyopathy (bortezomib)
Animal model of human
 disease
N/A EM, LC3-GFP Increased [17•]

DCM, dilated cardiomyopathy; EM, electron microscopy; LVAD, left ventricular assist device; N/A, not available.